BioSpace News Archive

NImmune Biopharma today announced the launch of a research collaboration with the NIMML Institute (“NIMML”), a nonprofit institute dedicated to the discovery of novel immune-mediated precision medicines.

Stoke Therapeutics, Inc. today announced that management will present at the BofA Securities Health Care Conference on Thursday, May 11, 2023, at 11:00 a.m. ET. (8:00 a.m. PT).

Apertura Gene Therapy today announced that academic collaborator and scientific co-founder, Ben Deverman, PhD, Senior Director of Vector Engineering and Institute Scientist at the Broad Institute of MIT and Harvard, will present at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT).

Pulse Biosciences, Inc. today announced the appointment of Gansevoort “Gan” Dunnington, M.D. as its Chief Medical Officer.

Forge Biologics, a leading manufacturer of genetic medicines, today announced a gene therapy development and manufacturing collaboration with Labcorp (NYSE: LH), a leading global life sciences company.

The recent national conversation on hepatitis C (HCV) is an encouraging step towards viral hepatitis elimination in the U.S. With its long history of leadership in viral hepatitis, Gilead continues to support efforts that focus on HCV elimination.

Exscientia plc (Nasdaq: EXAI) today announced the appointment of Professor Franziska Michor, Ph.D. to its Board of Directors.

GlycoMimetics, Inc. today reported its financial results and highlights for the first quarter ended March 31, 2023.

Deciphera Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update.

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent, multi-center study in the Archives of Dermatological Research providing a direct chain of evidence that use of DecisionDx®-Melanoma test results to guide radiological surveillance could lead to improved patient outcomes.